undamentalytics Newsletter
Sign in

Vivos Therapeutics, Inc. revenue

Vivos Therapeutics, Inc.'s revenue was $17.4m in fiscal 2025, up 16.0% on the year before. Since fiscal 2019 ($11.4m) it has grown at a compound 7.4% a year. Over the last twelve months it was $20.9m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1113171614151721
Growth on the year before—+14.7%+29.2%−5.1%−13.9%+8.9%+16.0%—
Gross profit9101310891113
Gross margin76.0%79.7%74.6%62.5%59.9%60.0%60.4%61.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Services $11M ▲ 53.1%
Products $6.5M ▼ 17.6%
Sleep Testing Services $6M ▲ 371.2%
Appliances $3.3M ▼ 41.5%
Tooth Positioners $3.2M ▲ 41.2%
Treatment Centers $2.2M —
Sponsorship Seminar Other $1.2M ▼ 37.0%
Billing Intelligence Services $686,000 ▼ 18.3%
VIP $491,000 ▼ 80.2%
Myofunctional Therapy Services $337,000 ▼ 44.7%

These categories overlap or exclude eliminations, so shares aren't shown.

From Vivos Therapeutics, Inc.'s 10-K filed April 15, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Vivos Therapeutics, Inc. $20.9m 45.2% 10.6%
Nephros Inc $20.7m 24.2% 19.3%
Jin Medical International Ltd. $20.7m -12.0% —
Sonoma Pharmaceuticals, Inc. $21.9m 47.0% 19.9%
Baird Medical Investment Holdings Ltd $22.5m -39.2% —
Sensus Healthcare, Inc. $17.5m -53.4% -16.5%

Compare with peers

Head to head: NEPH vs VVOSVVOS vs ZJYLSNOA vs VVOSBDMD vs VVOS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Vivos Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Vivos Therapeutics, Inc.